KORU Medical Systems, Inc. KRMD
Set alert
2.99 USD -0.24 -7.43%
At close · Oct 30
3.02 +0.03 +1.00%
After hours · Oct 30, 4:00 PM ET
2.99 Day range 3.25
2.93 52-week range 6.52
- YTD
- -48.54%
- 1 year
- -23.33%
- Open
- 3.24
- Prev close
- 3.23
- Mkt cap
- 138.05M
- Vol
- 165.22K
- Avg vol
- 241.15K
- EPS
- -0.04
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.99
- High
- 3.25
- Forward P/E
- -43.89
- Beta
- 0.41
- Short ratio
- 11.67
- Inst. own
- 54.38%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 3.27
- 200-d avg
- 2.59
- 1y target
- 4.90
Financial health
Altman Z-Score
8.61 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 1
Valuation
P/E -102×
FY 2016 5y median -29.6× FY 2025
P/S 6.5×
FY 2016 5y median 5.7× FY 2025
P/B 15.7×
FY 2016 5y median 5.5× FY 2025
P/FCF -571×
FY 2016 5y median -28.4× FY 2025
EV/EBITDA -146×
FY 2016 5y median -18.4× FY 2025
EV/Sales 6.4×
FY 2016 5y median 5.1× FY 2025
FCF Yield -0.2%
FY 2016 5y median -3.5% FY 2025
Profitability
Gross Margin 62.3%
FY 2016 5y median 58.6% FY 2025
Operating Margin -7.2%
FY 2016 5y median -29.9% FY 2025
Net Margin -6.4%
FY 2016 5y median -19.4% FY 2025
ROE -15.5%
FY 2016 5y median -27.6% FY 2025
ROIC -14.5%
FY 2016 5y median -24.1% FY 2025
ROA -9.4%
FY 2016 5y median -20.5% FY 2025
Growth (YoY)
Revenue 22.2%
FY 2016 FY 2025
Operating Income 53.9%
FY 2016 FY 2025
EPS (diluted) 56.1%
FY 2016 FY 2025
Free Cash Flow 70.9%
FY 2016 FY 2025
Financial Health
Current Ratio 2.4×
FY 2016 5y median 4.3× FY 2025
Quick Ratio 2.0×
FY 2016 5y median 3.4× FY 2025
Debt / Equity 0.2×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA 3.0×
FY 2016 5y median 1.2× FY 2025
Interest Coverage 0.0×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31